Breakthrough in Colorectal Cancer Treatment with Immunotherapy
Researchers have announced a significant breakthrough in colorectal cancer treatment, revealing that certain tumors can be eradicated using immunotherapy alone, without the need for chemotherapy or surgery. This development, highlighted by Memorial Sloan Kettering Cancer Center, focuses on colorectal cancers with deficient mismatch repair (dMMR) or high microsatellite instability (MSI-H). Early clinical trials have shown complete tumor remission in some patients, suggesting a potential shift towards less invasive treatment options. This approach could reduce the need for surgeries, which often result in life-altering consequences such as colostomies and long-term bowel dysfunction. 
